financetom
Business
financetom
/
Business
/
NXT Energy Solutions Q2 net loss widens to C$6.98 mln
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NXT Energy Solutions Q2 net loss widens to C$6.98 mln
Aug 11, 2025 3:39 PM

Overview

* NXT Energy Q2 SFD-related rev reaches C$1.66 mln

* Company posts Q2 net loss of C$6.98 mln, impacted by non-cash charges

* Convertible debentures worth $5.675 mln converted to common shares

Outlook

* Company plans SFD surveys for remainder of 2025 and contract bookings for 2026

* NXT Energy aims to deliver meaningful shareholder value through strong fundamentals

Result Drivers

* REPEAT CONTRACTS - SFD revenues driven by repeat contracts in high potential regions, per CEO Bruce G. Wilcox

* CONVERTIBLE DEBENTURES - $5.675 mln of convertible debentures converted to common shares, affecting net income

* NON-CASH CHARGES - Net loss impacted by non-cash charges including stock-based compensation and remeasurement loss

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 EPS -C$0.08

Q2 Net -C$6.98

Income mln

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bristol-Myers Squibb Says Application to Expand Breyanzi Indication Validated in EU
Bristol-Myers Squibb Says Application to Expand Breyanzi Indication Validated in EU
Aug 19, 2024
07:59 AM EDT, 08/19/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Monday that its application to expand the indication for its CAR T cell therapy Breyanzi has been validated by the European Medicines Agency, paving the way for its review. The company said it submitted a Type II variation application for Breyanzi, or lisocabtagene maraleucel, to include treatment...
Dover Buys Criteria Labs
Dover Buys Criteria Labs
Aug 19, 2024
07:53 AM EDT, 08/19/2024 (MT Newswires) -- Dover (DOV) said Monday it has bought Criteria Labs, a provider of radio frequency device and microelectronic engineering services. Financial terms were not disclosed. Criteria Labs, which has been integrated within Dover's Microwave Products Group, will support the group's ability to meet certain requirements crucial to electronic warfare and communication systems, Dover said....
Freightos Acquires Shipsta in Cash and Stock Deal
Freightos Acquires Shipsta in Cash and Stock Deal
Aug 19, 2024
07:59 AM EDT, 08/19/2024 (MT Newswires) -- Freightos ( CRGO ) said Monday it acquired Shipsta, a freight-tender procurement platform, for a price that includes a cash payment of 4.5 million euros ($5 million) and approximately 640,000 Freightos ( CRGO ) shares issued to a key Shipsta shareholder. Freightos ( CRGO ) said it expects Shipsta to contribute about $800,000...
Gibraltar Industries Appoints Joseph Lovechio as CFO
Gibraltar Industries Appoints Joseph Lovechio as CFO
Aug 19, 2024
07:53 AM EDT, 08/19/2024 (MT Newswires) -- Gibraltar Industries ( ROCK ) said Monday that it has appointed Joseph Lovechio as chief financial officer, effective immediately. Lovechio joins the company after 20 years with Whirlpool (WHR), most recently serving as CFO of the North America region since 2018. He will succeed Timothy Murphy who plans to retire but will continue...
Copyright 2023-2026 - www.financetom.com All Rights Reserved